옛 화면은 좌우로 밀어 볼 수 있습니다.

Publications

Projects :
Published Dates :
Select All
Novel GSK-3β Inhibitor Neopetroside A Protects Against Murine Myocardial Ischemia/Reperfusion Injury (cPMTb)
JACC Basic Transl Sci. 7(11):1102-1116 / 2022.09 [LINK]
Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis (cPMTb)
Sci Rep. 12(1):13395 / 2022.08 [LINK]
Aryl hydrocarbon receptor-targeted therapy for CD4+ T cell-mediated idiopathic pneumonia syndrome in mice (cPMTb)
Blood. 139(22):3325-3339 / 2022.06 [LINK]
Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses (cPMTb)
Toxicol Appl Pharmacol. 15:439:115928 / 2022.03 [LINK]
Molecular perturbations in pulmonary tuberculosis patients identified by pathway-level analysis of plasma metabolic features (cPMTb)
PLoS One.24;17(1):e0262545 / 2022.01 [LINK]
Metabolomics-guided global pathway analysis reveals better insights into the metabolic alterations of breast cancer (cPMTb)
J Pharm Biomed Anal. 5:202:114134 / 2021.08 [LINK]
Repression of PPARγ reduces the ABCG2-mediated efflux activity of M2 macrophages (cPMTb)
Int J Biochem Cell Biol. 130:105895 / 2021.01 [LINK]
Thymoquinone Suppresses Migration of Human Renal Carcinoma Caki-1 Cells through Inhibition of the PGE2-Mediated Activation of the EP2 Receptor Pathway (cPMTb)
Biomol Ther (Seoul). 29(1):64-72 / 2021.01 [LINK]
Increased hepatic acylcarnitines after oral administration of amiodarone in rats (cPMTb)
J Appl Toxicol. 40(7):1004-1013 / 2020.07 [LINK]
Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes (cPMTb)
Prostaglandins Leukot Essent Fatty Acids. 153:10205 / 2020.02 [LINK]